CoreCap Advisors, LLC
Position in BCLI — Brainstorm Cell Therapeutics Inc.
CIK 1902501
SOUTHFIELD, MI
Position in BCLI
as of Jun 30, 2025
· filed Aug 14, 2025
Position Value
$8
-$2 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $2,272,107 across 81 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
6,755 | $367,539 | |
| 2 | MRNA |
Moderna, Inc.
|
4,595 | $321,787 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,000 | $244,530 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
442 | $219,554 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315 | $196,415 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
280 | $150,346 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
52,020 | $145,656 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
428 | $135,286 |
All Filings in BCLI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-06-30 | $8 | 8 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10 | 8 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $18 | 8 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $74 | 133 | Shares | Sole | 2024-08-08 | |
| 2022-12-31 | $218 | 133 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $367 | 133 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $532 | 133 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||